Level 1: aetiology advanced |
1.i |
Infection induced |
(a) Shiga and shiga-like toxin-producing bacteria; enterohaemorrhagic Escherichia coli, Shigella dysenteriae type 1, Citrobacter freundii
|
(b) Streptococcus pneumoniae, neuraminidase and T-antigen exposure |
1.ii |
Disorders of complement regulation |
(a) Genetic disorders of complement regulation |
(b) Acquired disorders of complement regulation, e.g. anti-factor H antibody |
1.iii |
von Willebrand proteinase, ADAMTS13, deficiency |
(a) Genetic disorders of ADAMTS13 |
(b) Acquired ADAMTS13 deficiency; autoimmune, drug induced |
1.iv |
Defective cobalamin metabolism |
1.v |
Quinine induced |
Level 2: aetiology unknown |
2.i |
Human immunodeficiency virus (HIV) |
2.ii |
Malignancy, cancer chemotherapy and ionising radiation |
2.iii |
Calcineurin inhibitors and transplantation |
2.iv |
Pregnancy, HELLP syndrome and oral contraceptive pill |
2.v |
Systemic lupus erythematosus and antiphospholipid antibody syndrome |
2 vi |
Glomerulopathy |
2.vii |
Familial, not included in part 1 |
2.viii |
Unclassified |